Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/2009
03/19/2009WO2008101448A4 Method of manufacturing 1-(2-deoxy-alpha-d-erythro-pentofuranosyl)-5-azacytosine
03/19/2009US20090076295 Photocleavable protecting groups
03/19/2009US20090076256 Degradation-resistant mononucleoside phosphate compounds
03/19/2009US20090075931 isotope exchanged capecitabine, used for the treatment of metastatic breast cancer; anticarcinogenic agents
03/19/2009US20090075930 for treating leukemia
03/19/2009US20090075920 Deuterium-enriched decitabine
03/19/2009US20090075342 Metabolic profile directed aptamer medicinal chemistry
03/19/2009US20090075253 Bioreactive agents
03/19/2009US20090071876 Desulfurizing agent manufacturing method and hydrocarbon desulfurization method
03/18/2009EP2036897A1 Stable rhodamine labeling reagent
03/18/2009EP2034834A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-BETA -D-RIBOFURANOSYL)-THIAZOLO[4,5-d]PYRIMIDIN-2,7-DIONE
03/18/2009EP1994042A4 Preparation of gemcitabine
03/18/2009CN101385738A Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
03/18/2009CN100469785C Method of reclaiming adenosine from low concentration Chinese caterpillar fungus fermentation waste water by large aperture adsorption resin
03/17/2009US7504499 Methods of attaching biological compounds to solid supports using triazine
03/17/2009US7504497 Thrombosis; anticoagulants; renal dialysis; bioavailability
03/17/2009US7504496 Water-soluble rhodamine dye conjugates
03/17/2009US7504495 Quencher compositions comprising anthraquinone moieties
03/17/2009US7504489 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR)
03/17/2009US7504215 Ligation; hybridization; photolithography; microRNA; microarrays
03/17/2009CA2380205C Novel bicyclonucleoside analogues
03/17/2009CA2355712C Antiviral nucleoside analogues
03/17/2009CA2322231C Process for the purification of s-adenosyl-l-methionine and for the preparation of the pharmaceutically acceptable salts thereof
03/12/2009WO2009030410A1 Improvements in or relating to compositions for the treatment or prophylaxis of viral infections
03/12/2009WO2009030075A1 PROCESS FOR PREPARING 2'-DEOXY-2',2'-DIFLUORO-β-CYTIDINE HYDROCHLORIDE
03/12/2009WO2008157751A3 Substituted imidazoheterocycles
03/12/2009US20090069557 Preparation of gemcitabine
03/12/2009US20090069556 Metabolically stable puromycin analogs
03/12/2009US20090069500 Label target and labeling reagents comprising rigid group backbones
03/12/2009US20090069268 Novel phosphoramidate compounds and methods of use
03/12/2009US20090069263 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof
03/12/2009US20090068751 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes
03/12/2009US20090068695 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity
03/12/2009US20090068125 Treatment for mucositis
03/11/2009EP2033647A1 Agent against psychosocial stresses
03/11/2009EP1165564B1 Process for preparing inhibitors of nucleoside metabolism
03/11/2009CN101384609A Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
03/11/2009CN101381388A dTDP-D-furan type fucose and preparation method and application
03/11/2009CN101381387A Method for preparing 2'-deoxy-2',2'-difluoro-beta-cytidine hydrochlorate
03/11/2009CN101381382A Method for producing deoxynucleotide acid or salt thereof
03/10/2009US7501506 Pentopyranosyl nucleic acid does not non-covalently bond or hybridize to naturally occurring DNA or RNA; conjugated through a covalent linkage to the biotin molecule; diagnosis, gene therapy
03/10/2009US7501504 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors; polymerization in the presence of deoxynucleotidyl transferase
03/10/2009US7501500 Inhibiting denaturation of nucleic acid duplexes
03/05/2009WO2009029888A2 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
03/05/2009WO2009029868A1 Phosphoramidite nucleoside analogs
03/05/2009WO2009029729A1 Amino tricyclic-nucleoside compounds, compositions, and methods of use
03/05/2009WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same
03/05/2009WO2009005382A3 Derivatives of nucleoside-5'-o-hypophosphates and their mono- and dithiohypophosphate analogues and the process for the manufacture thereof
03/05/2009WO2008154401A3 Carbocyclic bicyclic nucleic acid analogs
03/05/2009WO2008150729A3 N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
03/05/2009US20090062543 Uv excitable fluorescent energy transfer dyes
03/05/2009US20090062521 Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid
03/05/2009US20090062314 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
03/05/2009US20090062223 Amino tricyclic-nucleoside compounds, compositions, and methods of use
03/05/2009US20090062145 Labelled nucleotides
03/05/2009US20090061437 Nucleotide Analogs
03/05/2009US20090060888 Regulated transcription of targeted genes and other biological events
03/05/2009US20090060836 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue
03/05/2009CA2697837A1 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
03/04/2009CN101379073A Process for preparing an a2a-adenosine receptor agonist and its polymorphs
03/04/2009CN101379061A Inhibitors of E1 activating enzyme
03/04/2009CN101378725A Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
03/04/2009CN101376667A Intermediate for synthesizing azidothimidine, preparation thereof and use in azidothimidine synthesis
03/04/2009CN100465186C A composition and a method for inhibiting platelet aggregation
03/03/2009US7498426 Immunostimulatory oligonucleotide multimers
03/03/2009US7498425 Immunostimulatory oligonucleotide multimers
03/03/2009US7498320 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
03/03/2009CA2237368C 5'-deoxy-cytidine derivatives
02/2009
02/26/2009WO2008157688A3 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
02/26/2009US20090054369 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs
02/26/2009US20090054258 Nucleic Acid Labeling Methods
02/25/2009EP2027139A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiazolo [4, 5-d]pyrimidin-2-one
02/25/2009EP1490383B1 Methods and compositions for identifying and characterizing hepatitis c
02/25/2009CN101374850A DNA chip for diagnosis of corneal dystrophy
02/25/2009CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition
02/24/2009US7495095 useful in obtaining an oligonucleic acid capable of recognizing a specific base and transferring a nitrosyl group in a sequence-specific manner; sequence specific mutagenesis
02/24/2009US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use
02/19/2009WO2009023855A2 Tetrahydropyran nucleic acid analogs
02/19/2009WO2009006478A3 6-disubstituted bicyclic nucleic acid analogs
02/19/2009US20090048427 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
02/19/2009US20090048203 Substituted adenines and the uses thereof
02/19/2009US20090048202 Selective inhibitors of translesion dna replication
02/19/2009US20090048190 Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane
02/19/2009US20090048189 Tricyclic-nucleoside compounds for treating viral infections
02/19/2009US20090047712 Chemically cleavable phosphoramidite linkers
02/19/2009CA2696497A1 Tetrahydropyran nucleic acid analogs
02/18/2009EP2024380A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
02/18/2009CN101370945A Methods for identifying multiple DNA alteration markers in a large background of wild-type DNA
02/18/2009CN101367856A Methods and compositions for treating hepatitis c virus
02/18/2009CN100462441C Method of preparing a guanosine-group compound and an intermediate thereof
02/17/2009US7491818 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes
02/17/2009US7491807 A DNA sequence encoding a methyl CpG binding endonuclease protien of a size between about 60 and 75 kilodaltons containing an amino-terminal methyl CpG-binding domain, an internal segment rich in positively charged amino acids and a carboxy-terminal catalytic domain, having deoxyribonuclease activity
02/17/2009US7491677 Composite sample on support; concentration gradients
02/17/2009US7491495 Adhering nucleotide sequences to solid support; gene expression analysis
02/12/2009US20090042820 Tubulin Binding Anti Cancer Agents And Prodrugs Thereof
02/11/2009EP2021350A1 Phosphorylated a2a receptor agonists
02/11/2009CN101365791A Method for replication of nucleic acid and novel artificial base pair
02/11/2009CN101362787A Method for preparing telbivudine
02/11/2009CN100460417C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase
02/11/2009CN100460416C Method for preparing adenosine
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 201